Join to View Full Profile
401 North Broadway StreetWeinberg BLDGBaltimore, MD 21287
Are you Dr. Levis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Levis, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland and District of Columbia. He is affiliated with Johns Hopkins Hospital and is an Associate Professor of Oncology at Johns.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1999 - 2002- Johns Hopkins UniversityResidency, Internal Medicine, 1994 - 1997
University of California San Francisco School of MedicineClass of 1994
Certifications & Licensure
DC State Medical License 2017 - 2026
MD State Medical License 1997 - 2026
Publications & Presentations
PubMed
- Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax/ hypomethylating agents.Sabine Kayser, Khaled Sanber, Giovanni Marconi, Agnese Mattei, Marlise R Luskin
Haematologica. 2025-02-01 - Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML.Mark J Levis, Mehdi Hamadani, Brent R Logan, Richard J Jones, Anurag K Singh
Blood. 2025-01-07 - Reply to S. Fuji.Mark J Levis, Mehdi Hamadani, Mary M Horowitz, Yi-Bin Chen,
Journal of Clinical Oncology. 2024-11-10
Press Mentions
Improving Risk Stratification in Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia in ChildrenApril 21st, 2023- AML Research from ASH 2022: Novel Combinations and Evidence That “Less Is More”February 8th, 2023
- The Efficacy of ATO and ATRA for APLOctober 13th, 2021
- Join now to see all
